References
- Buckels JAC, Nordestgaard A. G., Wilson SE. Microporous vascular grafts do not require neointima for resistance to bacteremic infection. J Vasc Surg. 1987; 5: 198–202
- Fletcher J. P., Dryden M., Sorrell TC. Infection of vascular prostheses. Aust N Z J Surg. 1991; 61: 432–435
- Szilagyi D. E., Smith R. F., Elliot J. P., et al. Infection in arterial reconstruction with synthetic grafts. Ann Surg. 1974; 128: 225
- Wilson S. E., Wang S., Gordon HE. Perioperative antibiotic prophylaxis against vascular graft infection. South Med J. 1977; 70: 68–71
- Ahn S. S., Clem M. F., Braithwaithe B. D., et al. Laparoscopic aortofemoral bypass: Initial experience in an animal model. Ann Surg. 1995; 222: 677–683
- Sardelic F., Peng Y. A., Fletcher JP. Development of aStaphylococcus epidermidis vascular graft infection model in sheep. Aust N Z J Surg. 1995; 65: 503–506
- Nordestgaard A. G., Buckels JAC, Wilson SE. A laboratory model for the evaluation of thromboembolic complications of small diameter vascular prostheses. Br J Exp Pathol. 1986; 67: 839–849
- Nordestgaard A. G., Wilson SE. Neoendothelialization of small-diameter polytetrafluoroethylene arterial grafts is not delayed by aspirin and dipyridamole. J Vasc Surg. 1988; 7: 93–98
- Cordero JA, Jr, Darling R. C., Chang B. B., et al. In situ prosthetic graft replacement for mycotic thoracoabdominal aneurysms. Am Surg. 1996; 62: 35–39
- Yeager R. A., McConell D. B., Sasaki T. M., et al. Aortic and peripheral prosthetic graft infection: Differential management and causes of mortality. Am J Surg. 1985; 150: 36–43
- Goldstone J., Moore WS. Infection in vascular prostheses. Clinical manifestations and surgical management. Am J Surg. 1974; 128: 225–233
- Calligaro K. D., Veith FJ. Management of Infected Arterial Grafts. Quality Medical Publishing, St. Louis, MO 1968; 25–42
- Wilson S. E. The prevalence ofStaphylococcus aureus in the general surgery patient. Modern Med. 1989; 57: 18–27
- Bandyk D. F. Diagnosis and treatment of biomaterial associated vascular infections. Infect Dis Clin North Am. 1992; 6(3)719
- Calligaro K. D., Veith FJ. Management of Infected Arterial Grafts. Quality Medical Publishing, St. Louis, MO 1994; 3–15
- Ney A. L., Granja J. A., Schuster P. A., et al. The use of biodegradable amikacin microspheres to prevent vascular graft infection. J Surg Res. 1994; 57: 698–705
- Fletcher J. P., Dryden M., Munro R., et al. Establishment of a vascular graft infection model in the sheep carotid artery. Aust N Z J Surg. 1990; 60: 801–803
- Astrup A., Buluk K. Thromboplastic and fibrinolytic activities in vessels of animals. Circ Res. 1963; 13: 253–260
- Vogt P. R., von Segesser L. K., Goffin Y., et al. Eradication of aortic infections with the use of cryopreserved arterial homografts. Ann Thorac Surg. 1996; 62: 640–645